Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
By Dr Paul Shields Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realise the vast potential…
Read guide →Peptide drugs are highly regarded for their high potency, specificity, low side effects, and lower production costs compared to antibody-based therapies. However, challenges such as poor metabolic stability, m…
Read guide →Main One of the biggest bottlenecks in therapeutic development is that a large proportion of the proteins can currently not be targeted by classical small molecules administered orally 1 . Challenging targets …
Read guide →David J. Brayden- UCD Conway Institute, Veterinary Sciences Centre, University College Dublin, Belfield, Dublin, Ireland Rationale Oral administration of peptides for systemic delivery offers convenience for p…
Read guide →The clinical research world is advancing rapidly, with new drug development technologies and drug activation breakthroughs coming to light more often now than ever. Oral peptides are one such innovation that i…
Read guide →From Concept to Commercialization with CordenPharma The combination of our decades-long history of peptide drug substance development and supply and our track record of oral solid dosage form development and c…
Read guide →Oral peptide-based drugs are set to revolutionise the pharmaceutical industry, overcoming the long-standing challenge of poor bioavailability. Santosh Kulkarni reveals how new breakthroughs in drug discovery a…
Read guide →